PRESS RELEASE
Published April 4, 2023
The global alopecia market size is expected to reach USD 18,390.52 Million in 2030 and register a rapid revenue CAGR of 7.0%, according to the latest report by Reports and Data. Increasing number of funding and initiatives by governments across the world and rising awareness about alopecia treatment are major factors driving market revenue growth. Government organizations, such as National Alopecia Areata Foundation and American Hair Loss Association, are increasing healthcare spending by raising awareness about hair regrowth and available treatment options. The 2010 Affordable Care Act provides people with affordable access to healthcare insurance, benefiting economically disadvantaged patients. This results in an overall increase in treatment rate, which is expected to drive market growth.
Some major companies profiled in the market report are Merck & Co., Johnson & Johnson, Cipla Inc., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Lexington Intl., LLC., Hcell Inc., and Pfizer Inc.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/1334
Market Overview:
The research report assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. The report estimates the market size, market growth, and provides an accurate forecast for the key segments of the market for the forecast period of 2022-2030. The report also covers an in-depth analysis of the key competitors of the market, along with their growth strategies and business expansion plans.
The Alopecia Market has been segmented into key regions of the world and offers an analysis of growth rate, market share, market size, current and emerging trends, production and consumption ratio, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players in each region. A country-wise analysis of the market is offered in the report to gain a better understanding of the regional spread and progress of the Alopecia Market.
Further key findings from the report suggest,
- Based on route of administration, the tropical segment is expected to account for a significant revenue share between 2022 and 2030. Folliculitis decalvans, Lichen planopilaris, and severe alopecia areata are all treated with topical immunotherapy. This type of treatment involves applying substances to scalp, such as Squaric Acid Dibutyl Ester (SADBE), Dinitrochlorobenzene (DNCB), or Diphencyprone (DPCP). This affects immune response and results in an allergic rash (allergic contact dermatitis) that resembles poison oak or ivy. After around six months of treatment, roughly 40% of patients receiving topical immunotherapy grow new scalp hair. In addition, patients who successfully grow new scalp hair typically need to continue treatment to keep it growing. Its frequent side effects include redness, itching, and a rash at the application site. Furthermore, practice and prescription of topical immunotherapy is primarily handled by dermatologists and is not readily accessible.
- The topical medication minoxidil, also marketed under the brand name Rogaine, is simple to use and easily accessible Over-The-Counter (OTC). Minoxidil helps the hair grow more quickly, once the follicle is able to produce hair and is no longer being attacked by immune system. Topical minoxidil solutions typically available in 2 or 5 % concentrations. This therapy can be applied once or twice daily directly to scalp or any other area.
- Based on distribution channel, the online pharmacy segment is likely to expand with highest CAGR owing to its rising popularity due to its ease and convenience and increase demand of Minoxidil as online offers competitive prices.
- Based on end-uses, the wellness clinics segment is expected to account for a moderate revenue share during the forecast period. This is due to increasing wellness clinics that offer cutting-edge hair transplant techniques along with treatments and procedures to strengthen hair and reduce hair loss. Wellness clinics have clearly defined treatment plans, such as different modules for treatment, number of test procedures and others, for example, Follicular Unit Extraction (FUE) manual mechanized hair transplant process, which involves removing hair from donor area of scalp and implanting it in recipient area through tiny incisions. In a non-invasive technique, there are no stitches required.
- The Asia Pacific market is expected to register a steady revenue growth rate between 2022 and 2030. People experience challenges with hair damage and hair loss because of environmental factors such as changing climate in different parts of Asia. Along with rise in alopecia due to hereditary factors, bad lifestyle choices, autoimmune disorders, and chronic diseases are resulting in increase of treatment requirements. For instance, according to a survey done in 2020 by China Association of Health Promotion and Education, both men and women in the 20–40 age range in China accounted for over 250 million people who were experiencing hair loss. Owing to high amount of hair loss issues, complete baldness or patches on scalps, alopecia treatment products such as medicines, LLLT devices, surgeries, or use of cosmeceutical products will be in great demand in Asian regions, which will expand the alopecia market in Asia.
To understand how our Alopecia Market can bring difference to your business strategy:– https://www.reportsanddata.com/report-detail/alopecia-market
For this study, Reports and Data has segmented the global alopecia market based on type, disease type, gender, route of administration, age group, distribution channel, end-use, and region:
Type Outlook (Revenue, USD Million, 2019 – 2030)
- Pharmaceuticals
- Finasteride
- Minoxidil
- Corticosteroid
- Methotrexate
- JAK Inhibitors
- Dutasteride
- Other Medication
- LLLT Devices
- Hair Transplant
- Regenerative medicine
- Others
- Shampoo and Conditioner
- Supplements
Disease Type Outlook (Revenue, USD Million, 2019 – 2030)
- Androgenetic Alopecia
- Alopecia Areata
- Telogen Effluvium
- Frontal Fibrosing Alopecia
- Lichen Planopilaris
- Folliculitis Decalvans
- Other Disease Type
Gender Outlook (Revenue, USD Million, 2019 – 2030)
Route of Administration Outlook (Revenue, USD Million, 2019 – 2030)
Age Group Outlook (Revenue, USD Million, 2019 – 2030)
- <18 years
- 18-34 years
- 35-49 years
- >50 years
Distribution Channel Outlook (Revenue, USD Million, 2019 – 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channel
End-use Outlook (Revenue, USD Million, 2019 – 2030)
- Homecare Settings
- Dermatology Clinics
- Wellness Clinics
- Other End-uses
Regional Outlook (Revenue, USD Million, 2019 -2030)
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East & Africa
- UAE
- Saudi Arabia
- Africa
- Rest of Middle East
Request a customization of the report : https://www.reportsanddata.com/request-customization-form/1334
Key Advantages of Alopecia Market Report:
- Identification and analysis of the market size and competition
- Qualitative and quantitative analysis of the market data
- Data validated by industry experts after extensive primary and secondary research
- Extensive regional analysis of the Alopecia industry
- Profiling of key players along with their business overview, business strategies, deals and partnerships, and product portfolio
- SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
- Feasibility analysis and investment analysis to enable strategic investment decisions
- Analysis of opportunities, drivers, restraints, challenges, risks, and limitations
Conclusively, all aspects of the Alopecia Market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
Check our upcoming research reports @ https://www.reportsanddata.com/upcoming-reports
Visit our blog for more industry updates @ https://www.reportsanddata.com/blogs
Image Credit
Browse More Reports:
https://www.biospace.com/article/medical-tuning-fork-market-trends-revenue-key-players-growth-share-and-forecast-till-2028/
https://www.biospace.com/article/esomeprazole-sodium-market-size-share-industry-growth-trend-business-opportunities-challenges-drivers-and-restraint-research-report-by-2027/
https://www.biospace.com/article/connected-health-device-market-size-share-industry-key-features-growth-drivers-key-expansion-strategies-upcoming-trends-and-regional-forecast-by-2028/
https://www.biospace.com/article/compressor-nebulizer-market-analysis-development-opportunities-future-growth-and-business-prospects-by-forecast-to-2028/
The post Global Alopecia Market Size To Reach USD 18,390.52 Million at a CAGR of 7.0% In 2030 appeared first on Market O Graphics.
